Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
In times of financial crisis, knowing how to get emergency funds fast is crucial. Explore various options to secure the funds you need.
17,560 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A big move by an asset manager can ripple through a stock’s price and its story. This article explains what asset man...
A Spain-focused ETF is delivering roughly a 50% one-year return, eclipsing EZU by a wide margin and signaling a sharp...
A bold move in the crypto mining world is steering toward artificial intelligence compute. This article examines what...
Oakmark Select adds to discounted stocks in Q4, signaling a shift toward durable earnings as volatility persists. Nyg...
The Federal Reserve left its policy rate unchanged at its March 2026 meeting as inflation cools but the jobs market r...
Evernorth moves to go public through a SPAC merger, aiming to convert XRP exposure into a participatory, yield-genera...
With $5,000, you can build a solid starter portfolio that balances growth and risk. This guide shows a simple, repeat...
Bitcoin rose sharply after news that a five-day window for Iran talks could cool tensions, lifting broader markets. C...
Bhutan’s sovereign fund moved 519.7 BTC, worth about $37 million, to Binance, continuing a months‑long sell-off that ...
Anchorage Digital is introducing institutional custody for TRX, a regulatory milestone that could reshape near-term p...
Bitcoin extended its negative funding run, marking the longest streak in years. Analysts warn of rising short-squeeze...